Search

everythinglearnresearchcommunity

for

Search:↓

New sulfur-containing steroid analogs show promise for more targeted medical treatments.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.

Prolactin may affect hair growth differently based on gender and scalp area.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Minoxidil effectively treats female pattern hair loss.

Early diagnosis and treatment of TPP can prevent complications.

High doses of finasteride cause cell growth and tumors in mice.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Many young Italian women have hyperandrogenic disorders like PCOS, which are linked to age, body weight, and insulin resistance.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

The document concludes that there is no agreed-upon best method for measuring drug delivery within hair follicles and more research is needed to validate current techniques.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

5α reductase inhibitors treat hair loss but may cause sexual side effects and risks.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Finasteride reduces hair growth and is safe for women with excessive hair.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.